Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition

por de Joode, K., Oostvogels, A. A. M., GeurtsvanKessel, C. H., de Vries, R. D., Mathijssen, R. H. J., Debets, R., van der Veldt, A. A. M.
Publicado 2021

LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors

por Oosting, S., Van der Veldt, A.A.M., GeurtsvanKessel, C.H., Fehrmann, R.S.N., van Binnendijk, R.S., Dingemans, A-M.C., Smit, E.F.F., Hiltermann, T.J.N., den Hartog, G., Jalving, M., Westphal, T., Battacharya, A., van der Heiden, M., Blank, C.U., Koopmans, M.P., van Els, C.A., Rots, N.Y., van Baarle, D., Haanen, J.B.A.G., de Vries, E.G.
Publicado 2021

Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors

por Oosting, S.F., van der Veldt, A.A.M., Fehrmann, R.S.N., Bhattacharya, A., van Binnendijk, R.S., GeurtsvanKessel, C.H., Dingemans, A.-M.C., Smit, E.F., Hiltermann, T.J.N., den Hartog, G., Jalving, M., Westphal, T.T., de Wilt, F., Ernst, S.M., Boerma, A., van Zijl, L., Rimmelzwaan, G.F., Kvistborg, P., van Els, C.A.C.M., Rots, N.Y., van Baarle, D., Haanen, J.B.A.G., de Vries, E.G.E.
Publicado 2023

One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment

por van der Veldt, A.A.M., Oosting, S.F., Fehrmann, R.S.N., GeurtsvanKessel, C.H., van Binnendijk, R.S., Dingemans, A.-M.C., Smit, E.F., Hiltermann, T.J.N., Hartog, G. den, Jalving, M., Westphal, T.T., Bhattacharya, A., de Wilt, F., Ernst, S.M., Boerma, A., van Zijl, L., Rimmelzwaan, G.F., Kvistborg, P., van Els, C.A.C.M., Rots, N.Y., van Baarle, D., Haanen, J.B.A.G., de Vries, E.G.E.
Publicado 2023